We're hiring!
Join FinalDose
Build the DNA-triggered cancer cure. Small team, hard problems, real wet-lab loop.
Open
Biology — Delivery
FinalDose's platform requires delivery solutions tailored to each therapeutic indication. You will lead delivery engineering across multiple administration routes, optimizing lipid nanoparticle formulations for tissue-specific targeting and therapeutic efficacy. Your work will bridge in vitro formulation development with in vivo validation and ultimately support technology transfer for GMP manufacturing. This is a critical role linking our construct engineering with clinical-stage drug products.
Responsibilities
- Lead LNP delivery engineering across multiple administration routes, including local, systemic, and inhaled formulations
- Develop and optimize LNP formulations with full physicochemical characterization (DLS, encapsulation efficiency, zeta potential)
- Perform in vitro delivery optimization and hand off validated formulations to the in vivo team for animal studies
- Support CMO/CDMO selection and technology transfer for GMP-grade manufacturing
- Collaborate with biology teams to evaluate delivery efficiency using functional readouts (editing efficiency, reporter assays) in cell lines and primary cells
Required
- Ph.D. in pharmaceutical sciences, drug delivery, biomedical engineering, or chemical engineering
- 3–5+ years of hands-on experience with lipid nanoparticle formulation
- Demonstrated expertise in at least two of the following: mRNA-LNP encapsulation and delivery, tissue-targeted delivery (SORT technology or ionizable lipid screening), inhaled or pulmonary drug delivery
- Experience with microfluidic mixing and formulation scale-up
- In vitro delivery characterization in cell lines and primary cells
Preferred
- Experience with intravesical or local drug delivery
- CMC or technology transfer experience with a CDMO
- Air-liquid interface (ALI) culture and aerosol delivery expertise
- Awareness of GMP manufacturing processes and requirements